© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Search results for

Tip: Use operators exact match "", AND, OR to customise your search. You can use them separately or you can combine them to find specific content.
There are 369,486 results that match your search.369,486 results
  • The Eu400m loan for Cemex España has closed over-subscribed by more than three-quarters. The deal is in documentation and should be signed today (Friday). It is unlikely that the borrower will take an increase. Mandated lead arrangers are BBVA and SG.
  • There are more than a few observers and competitors, so we are told, who would love to see Goldman Sachs slip on a banana skin. We can understand why. The problem with Goldie is that it doesn't make the slightest attempt to be user-friendly. With very few exceptions, Goldie folk are glum. They don't often smile and they are prone to talk in very short sentences.
  • Rating: Aa3/AA-
  • Rating: AA-/AAA
  • Standard Life will demutualise, but at a slow pace.
  • Central banks dominated talk and action in the London and New York swap markets this week. The ECB decided not to cut rates, which steepened the euro swap curve, while in the dollar market dealers were sitting tight for the next March non-farm payroll figure at close yesterday (Thursday).
  • Oriflame Cosmetics signed a five year Eu225m revolving facility which is fully underwritten by SEB. The deal will be syndicated shortly.
  • Goldman Sachs and UBS have been appointed to manage Swiss Life's Sfr1.15bn ($912m) capital increase, involving new shares and convertible bonds.
  • Citigroup continues to lead the market in EuroMTN deals for corporates by a clear margin. The house is nearly $700m ahead of its nearest rival JP Morgan, having led $1.6bn of deals, as opposed to JP Morgan's $938m.
  • The highly contested mandate for a $650m facility for Swedish medical technology and healthcare company Gambro has been awarded to three banks ? one Nordic firm and two international banks.